Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus

Fundamental and Clinical Pharmacology

Volumn 19, Issue 2, 2005, Pages 187-193

  Fanos, Vassilios ^a   Benini, Daniela ^b   Verlato, Giuseppe ^c   Errico, Gabriella ^d   Cuzzolin, Laura ^d  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Negrar Hospital   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

Ibuprofen; Kidney; PDA; Prematures

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE; DOPAMINE; FUROSEMIDE; IBUPROFEN; IBUPROFEN LYSINE; INDOMETACIN; INDOMETACIN MEGLUMINE; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; GESTATIONAL AGE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; NEPHROTOXICITY; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MATERNAL AGE; RETROSPECTIVE STUDIES;

EID: 17144402532     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2004.00314.x     Document Type: Article

References (49)

1. Fanos V., Cataldi L. Antibacterial-induced nephrotoxicity in the newborn. Drug Saf. (1999) 20 245-267.
2. Perlman J.M., Tack E.D., Martin T., Shackelford G., Amon E. Acute systemic organ injury in term infants after asphyxia. Am. J. Dis. Children (1989) 143 617-621.
3. Dudell G., Gersony M. Patent ductus arteriosus in neonates with severe respiratory disease. J. Pediatr. (1984) 104 915-920.
4. Zager R.A. Endotoxemia, renal hypoperfusion and fever: interactive risk factors for aminoglycoside and sepsis-associated acute renal failure. Am. J. Kidney. Dis. (1992) 20 223-230.
5. Clyman R.I. Medical treatment of patent ductus arteriosus in premature infants. in: Long W.A. (Ed.). Fetal and neonatal cardiology. W.B. Saunders, Philadelphia. PA, 1990. pp. 682-690.
6. Stefano J.L., Abbasi S., Pearlman S.A., Spear M.L., Esterly K.L., Bhutani V.K. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome: effects on pulmonary compliance and ventilation. Am. Rev. Respir. Dis. (1991) 143 236-239.
7. Cotton R.B., Stahlman M.T., Bender H.W., Graham T.P., Catterton W.Z., Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus. J. Pediatr. (1978) 93 647-651.
8. Yeh T.F., Luken J.A., Thaliji A., Raval D., Carr I., Pildes R.S. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus: a double-blind controlled study. J. Pediatr. (1981) 98 137-145.
9. Gersony W.M., Peckham G.J., Ellison C.R., Miettinen O.S., Nadas A.S. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J. Pedialr. (1983) 102 895-906.
10. Rennie J.M., Doyle J., Cooke R.W.I. Early administration of indomethacin to prcterm infants. Arch. Dis. Child. (1986) 61 233-238.
11. Mahony L., Carnero V., Brett C., Heymann M.A., Clyman R.I. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N. Engl. J. Med. (1982) 306 506-510.
12. Cotton R.B., Haywood J.L., Fitzgerald G.A. Symptomatic patent ductus arteriosus following prophylactic indomethacin. Biol. Neonate (1991) 60 273-282.
13. Krueger E., Mellander M., Bratton D., Cotton R. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J. Pediatr. (1987) 111 749-754.
14. Ment L.R., Oh W., Ehrenkranz R.A. et al. Low dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics (1994) 93 543-550.
15. Betkerur M.V., Yeh T.F., Miller K., Glasser R.J., Pildes R.S. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics (1981) 68 99-102.
16. Van Bel F., Guit G.L., Schipper J., Van der Bor M., Baan J. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J. Pediatr. (1991) 118 621-626.
17. Lin Y.J., Tsai Y.J., Chen J.S. et al. Renal effects and urinary excretion of prostaglandin following indomethacin therapy in premature infants with patent ductus arteriosus. Acta. Pediatr. Sin. (1995) 36 104-107.
18. Laudignon N., Chemtob S., Bard H., Aranda J.V. Effect of indomethacin on the cerebral blood flow velocity of premature newborns. Biol. Neonate (1988) 54 254-262.
19. Kuo C.Y. Treatment of patent ductus arteriosus with low-dose indomethacin in very low birth weight neonates with impairment of renal function: report of three cases. J. Perinat. Med. (1996) 24 657-660.
20. Coceani F., White E., Bodach E., Olley P.M. Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can. J. Physiol. Pharmacol. (1979) 57 825-831.
21. Chemtob S., Beharry K., Barna T., Varma D.R., Aranda J.V. Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr. Res. (1991) 30 106-111.
22. Malcom D.D., Segar J.L., Robillard E., Chemtob S. Indomethacin compromises hemodynamics during positive-pressure ventilation, independently of prostanoids. J. Appl. Physiol. (1993) 74 1672-1678.
23. SoRelle R. Ibuprofen as effective as indomethacin for patent ductus arteriosus. Circulation (2000) 102 E9007-E9008.
24. Van Overmeire B., Smets K., Lecoutere D. et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N. Engl. J. Med. (2000) 343 674-681.
25. Lago P., Bettiol T., Salvadori S. et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomized controlled trial. Eur. J. Pediatr. (2002) 161 202-207.
26. Patel J., Roberts I., Azzopardi D., Hamilton P., Edwards A.D. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr. Res. (2000) 47 36-42.
27. Mosca F., Bray M., Lattanzio M., Fumagalli M., Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J. Pediatr. (1997) 131 549-554.
28. Pezzati M., Vangi V., Biagiotti R., Bertini G., Cianciulli D., Rubaltelli F. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J. Pediatr. (1999) 135 733-738.
29. Aranda J.V., Varvarigou N., Beharry K., Modanlou H., Bardin C.L., Papageorgiou A. The effect of early intravenous ibuprofen on renal function in premature newborns. Pediatr. Res. (1994) 37 361A (abstr.).
30. Kauffman R.E., Nelson M.V. Effect of age on ibuprofen pharmacokinetics and antipyretic response. J. Pediatr. (1992) 121 969-973.
31. Guignard J.P., Drukker A. Why do newborn infants have a high plasma creatinine? Pediatrics (1999) 103 e49.
32. Armitage P., Berry G. Statistica medica: metodi statistici per la ricerca in medicina. McGraw-Hill Libri Italia, Milan, Italy, 1996.
33. Fanos V., Khoory B.J., Cataldi L. Postischaemic acute renal failure in newborns: physiopathological aspects and early diagnosis, in: Cataldi L., Fanos V. & Simeoni U. (Eds). Neonatal nephrology in progress, Agorà. Lecce, Italy, 1996. pp. 237-249.
34. Clyman R.I. Ibuprofen and the patent ductus. New Engl. J. Med. (2000) 343 728-730.
35. Sakhalkar V.S., Merchant R.H. Therapy of symptomatic patent ductus arteriosus in preterms using mefenamic acid and indomethacin. Indian Pediatr. (1992) 29 313-318.
36. Van Overmeire B., Brus F., Van Acker K.J. et al. Aspirin versus indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatr. Res. (1995) 38 886-891.
37. Van Overmeire B., Follens I., Hartmann S., Mahieu L., Van Reempt P. Intravenous ibuprofen for the treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatr. Res. (1996) 39 250A.
38. Clive D.M., Stoff J.S. Renal syndromes associated with non-steroidal antiinflammatory drugs. New Engl. J. Med. (1984) 310 563-572.
39. Palmer B.F. Renal complications associated with the use of nonsteroidal anti-inflammatory agents. J. Invest. Med. (1995) 43 516-533.
40. Gallini F., Maggio L., Romagnoli C., Marrocco G., Tortorolo G. Progression of renal function in preterm neonates with gestational age ≤32 weeks. Pediatr. Nephrol. (2000) 15 119-124.
41. Varvarigou A., Bardin C.L., Beharry K., Chemtob S., Papageorgiou A., Aranda J.V. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA (1996) 275 539-544.
42. De Carolis M.P., Romagnoli C., Polimeni V. et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur. J. Pediatr. (2000) 159 364-368.
43. Dani C., Bertini G., Reali M.F. et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatr. (2000) 89 1369-1374.
44. Van Overmeire B., Follens I., Hartmann S., Creten W.L., Van Acker K.J. Treatment of patent ductus arteriosus with ibuprofen. Arch. Dis. Child. (1997) 76 179-184.
45. Yeh T.F., Wilks A., Singh J., Betkerur M., Lilien L., Phildes R.S. Furosemide prevents renal side effects of indomethacin therapy in preterm infants with persistent ductus arteriosus. J. Pediatr. (1982) 101 433-437.
46. Fajardo C.A., Whyte R.K., Steele B.T. Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus. J. Pediatr. (1992) 121 771-775.
47. McIntire S.C., Rubenstein R.C., Gartner J.C., Gilboa N., Ellis D. Acute flank pain and reversible renal dysfunction associated with nonsteroidal antiinflammatory drug use. Pediatrics (1993) 92 459-460.
48. Lesko S.M., Mitchell A.A. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA (1995) 273 929-933.
49. Lesko S.M., Mitchell A.A. Renal function after short-term ibuprofen use in infants and children. Pediatrics (1997) 100 954-957.